Henry Schein Stock Price, News & Analysis

Henry Schein (Nasdaq: HSIC) will release its third quarter 2025 financial results before the market opens on Tuesday, November 4, 2025. The company will host a live webcast of its earnings conference call the same day beginning at 8:00 A.M. ET.

Speakers include Stanley M. Bergman, Chairman and CEO, and Ronald N. South, SVP and CFO. Investors can access the live call and a replay via the company investor website at https://investor.henryschein.com/webcasts.

The Aspen Group (NASDAQ:HSIC) announced a nationwide partnership with Planmeca to deploy advanced digital imaging across its Aspen Dental network of more than 1,100 locations on Oct. 15, 2025. Selected hardware includes Planmeca Viso and ProMax CBCT units plus ProX, ProSensor HD and ProX GO 2D, featuring Planmeca CALM and Ultra Low Dose protocols to reduce retakes and radiation exposure.

Henry Schein will support installation with a nationwide team of over 900 technicians, warranty options, and integration of Planmeca Romexis software and Planmeca Insights for real-time device data and operational monitoring.

Henry Schein (Nasdaq: HSIC), the leading provider of healthcare products and services to dental and medical practitioners, has announced a new $750 million share repurchase program. This initiative comes in addition to the company's existing $500 million repurchase program announced in January 2025.

The new authorization represents approximately 9.0% of outstanding shares at the current stock price, with the company having 118.6 million shares outstanding as of September 8, 2025. The purchases will be conducted through open market or negotiated transactions, demonstrating management's confidence in their 2025-2027 BOLD+1 Strategic Plan.

Henry Schein Medical (NASDAQ:HSIC) has expanded its SolutionsHub by partnering with Colaborate, a management consulting firm specializing in medical laboratory services. The collaboration aims to enhance clinical laboratory operations across the United States by combining Colaborate's consulting expertise with Henry Schein's extensive network and capabilities.

Colaborate, established in 2005, has served over 500 institutions with services including billing, compliance assessments, consolidation assessments, and performance enhancements. The partnership will help laboratories address financial pressures and regulatory demands while improving operational efficiency and financial sustainability.

Henry Schein (NASDAQ:HSIC), the world's largest provider of healthcare solutions for dental and medical practitioners, has announced its participation in three major investor conferences in September 2025.

The company will present at the Wells Fargo Healthcare Conference in Boston on September 4, the Baird Global Healthcare Conference in New York City on September 10, and the Bank of America Global Healthcare Conference in London on September 24. All presentations will be accessible via live webcast on the company's website, with replays available afterward.

Henry Schein (Nasdaq: HSIC) has launched its 28th annual "Back to School" program, a global corporate citizenship initiative benefiting over 5,200 students across 45 locations in the U.S., Canada, Italy, Spain, the U.K., and Ireland.

The program, which has helped more than 75,000 children since 1998, involves Team Schein Members (TSMs) partnering with non-profit organizations to provide backpacks filled with school supplies and oral hygiene kits to underserved children. At the company's headquarters event in Melville, N.Y., 400 pre-identified students received backpacks, supplies, and gift cards for school outfits, alongside enjoying family activities and accessing free books donated through partnerships with KPMG LLP and First Book.

Henry Schein (NASDAQ: HSIC) reported its Q2 2025 financial results, with total net sales increasing 3.3% to $3.2 billion. The company's GAAP diluted EPS decreased to $0.70 from $0.80 in Q2 2024, while non-GAAP diluted EPS fell to $1.10 from $1.23.

Key highlights include 1.9% internal sales growth, 0.8% growth from acquisitions, and a 0.6% increase from foreign currency exchange. The company maintained its 2025 guidance, expecting non-GAAP diluted EPS of $4.80-$4.94, sales growth of 2-4%, and mid-single digit Adjusted EBITDA growth.

During Q2, Henry Schein implemented a restructuring plan with expected annual run-rate savings of over $100 million by end-2025, and completed significant share repurchases totaling 3.7 million shares for $259 million.

Henry Schein One (NASDAQ:HSIC) has launched Forms, a digital intake solution for Dentrix and Dentrix Ascend platforms, with over 1,000 dental practices adopting it in the first month. The solution features mobile-friendly customizable forms, ID and insurance card scanning, and secure two-factor authentication for virtually touchless patient check-in.

Early adoption data shows 90% form completion rates by patients, streamlining the pre-appointment process. The platform includes multilingual support, automated data integration, and centralized form management for dental service organizations (DSOs). Forms is available as part of standard Ascend upgrades and included in Patient Engage and Lighthouse packages, with separate pricing options for Dentrix users.

Henry Schein (Nasdaq: HSIC), the leading provider of healthcare solutions for dental and medical practitioners, has scheduled its Q2 2025 earnings release and conference call for Tuesday, August 5, 2025. The financial results will be released before market open, followed by a live webcast at 8:00 a.m. ET.

The earnings call will feature presentations from Chairman and CEO Stanley M. Bergman and CFO Ronald N. South. Investors can access the webcast through the company's investor relations website, with a replay available after the presentation.